You are here

Xyrem

Jazz, Hikma must face 'reverse payment' claims over narcolepsy drug

Reuters

Tue, 08/27/24 - 10:32 pm

reverse payments

Jazz looks at strategic options, including possible sale or unit divestiture

Fierce Pharma

Fri, 10/20/23 - 11:58 am

Jazz Pharma sues FDA over approval of rival narcolepsy drug

Medical Marketing and Media

Tue, 06/27/23 - 11:29 am

Jazz brings the noise to the FDA with lawsuit over approval of Avadel's narcolepsy drug Lumryz

Fierce Pharma

Sun, 06/25/23 - 09:41 pm

Jazz Pharmaceuticals

Avadel Pharmaceuticals

With FDA nod for Lumryz, Avadel is set to Jazz up the narcolepsy market

Fierce Pharma

Tue, 05/2/23 - 11:41 am

Federal Circuit court halts delisting of Jazz narcolepsy drug patent from the Orange Book

Endpoints

Thu, 12/15/22 - 11:04 pm

In Jazz case, FTC urges court to delist patent on blockbuster Xyrem

Fierce Pharma

Mon, 11/14/22 - 10:55 am

Avadel gets tentative FDA nod for rival to Jazz narcolepsy drug

Fierce Pharma

Tue, 07/26/22 - 11:25 am

Upcoming events – Avadel takes on Jazz and Axovant awaits early results

EP Vantage

Fri, 02/14/20 - 10:35 am

Jazz Pharmaceuticals

Parkinson's Disease

As investors fret about Xyrem durability, Jazz spends $52M+ upfront to swallow neuro-focused biotech

Endpoints

Wed, 08/14/19 - 10:19 am

Jazz's narcolepsy treatment passes Phase 3 test

Biopharma Dive

Wed, 03/27/19 - 11:39 am

Jazz Pharmaceuticals

U.S. court denies Jazz Pharma bid to revive narcolepsy drug patents

Reuters

Sat, 07/14/18 - 01:31 pm

Jazz Pharmaceuticals

3 Reasons Jazz Pharmaceuticals Stock Could Fall

Motley Fool

Sun, 06/18/17 - 11:38 pm

Jazz Pharmaceuticals

Jazz Pharmaceuticals stock surges 7% on settlement with Hikma over generic drug

Marketwatch

Thu, 04/6/17 - 09:36 am

Jazz Pharmaceuticals

Top 25 rare disease brands, by sales

Medical Marketing and Media

Wed, 02/15/17 - 11:20 am

Teva Pharmaceutical

Jazz Pharmaceuticals

FDA approves generic version of Jazz Pharma's sleep disorder drug

Yahoo/Reuters

Tue, 01/17/17 - 10:10 pm

Jazz Pharmaceuticals

Jazz Pharma Could Be Worth Over $200 If Xyrem Adds Long-Term Value: Here's How

Yahoo/Benzinga

Fri, 07/31/15 - 03:12 pm

Jazz Pharmaceuticals

Jazz Pharmaceuticals (JAZZ) Starts Late-Stage Study on Xyrem

Yahoo/Zacks.com

Wed, 12/3/14 - 09:40 am

Jazz Pharmaceuticals

The top 10 most expensive drugs of 2013

Fierce Pharma

Tue, 10/14/14 - 10:05 am

10 big brands keep pumping out big bucks, with a little help from price hikes

Fierce Pharma Marketing

Wed, 05/7/14 - 03:42 pm

Jazz Pharmaceuticals

Teva Pharmaceuticals

Pages